Want to join the conversation?
$MYL's European Generics segment had adjusted sales of approx. $630MM in 3Q15, a 95% constant currency increase versus 3Q14. This was largely attributed to the contribution of the EPD business. Legacy business grew 6% YoverY on a constant currency basis due to sales of new products and higher volumes on existing ones, mainly in Italy and France.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?